Following the mandate given by the European Commission to the SCCS in November 2019, within the framework of the evaluation of ingredients listed as nanomaterials, the Scientific Committee has just published its Preliminary Opinions on the safety of seven ingredients derived from gold and platinum. They were adopted at the CSSC plenary meeting of 30-31 March 2020 and are open for comments until 14 June 2021.
Gold [nano], Colloidal Gold [nano], Gold Thioethylamino Hyaluronic Acid [nano] and Acetyl heptapeptide-9, Colloidal gold [nano]
Background
The Commission services received under Article 16 of the Cosmetics Regulation via the Cosmetic Product Notification Portal (CPNP):
• 236 notifications for cosmetic products containing Gold (68 notifications) and Colloidal Gold (168 notifications)
• 11 notifications for cosmetic products containing Gold Thioethylamino Hyaluronic Acid
• 18 notifications for cosmetic products containing Acetyl heptapeptide-9, Colloidal gold
The Commission has concerns on the use of Gold - Colloidal Gold, Gold Thioethylamino Hyaluronic Acid and Acetyl heptapeptide-9, Colloidal gold in nano form because of the potential for nanoparticles to be absorbed dermally or across a mucous membrane and to enter cells.
For an exhaustive background information, see the article
• Nanos (Gold, Platinum): Requests for Opinions to SCCS, CosmeticOBS, 25 November 2019
Opinion
1. In view of the above, and taking into account the scientific data provided, does the SCCS consider the nanomaterials Gold and Colloidal Gold, Gold Thioethylamino Hyaluronic Acid and Acetyl Heptapeptide-9 Colloidal Gold are safe when used in leave-on skin cosmetic products according to the maximum concentrations and specifications, taking into account reasonably foreseeable exposure conditions?
The SCCS has considered all the …
